Search Results - "Er, Puchun"
-
1
Tumor Remission and Tumor-Infiltrating Lymphocytes During Chemoradiation Therapy: Predictive and Prognostic Markers in Locally Advanced Esophageal Squamous Cell Carcinoma
Published in International journal of radiation oncology, biology, physics (01-10-2019)“…Clinical tools are unavailable for accurate prediction of pathologic responses to chemoradiation therapy (CRT) among patients with esophageal squamous cell…”
Get full text
Journal Article -
2
Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases
Published in BMC cancer (03-09-2020)“…In 1997, the Radiation Therapy Oncology Group (RTOG) put forward the recursive partitioning analysis classification for the prognosis of brain metastases…”
Get full text
Journal Article -
3
Tumor regression after combination of radiation and PD-1 antibody nivolumab treatment in a patient with metastatic mediastinal leiomyosarcoma: a case report
Published in Cancer biology & therapy (03-04-2019)“…The PD-1/PD-L1 axis is characterized as an important checkpoint of immune activation, particularly through negatively regulating T cell function. Although…”
Get full text
Journal Article -
4
Is There a Role for Post-Mastectomy Radiotherapy for T1-2N1 Breast Cancers With Node-Positive Pathology After Patients Become Node-Negative Pathology Following Neoadjuvant Chemotherapy?
Published in Frontiers in oncology (30-06-2020)“…Purpose: To assess the benefit of post-mastectomy radiotherapy (PMRT) in breast cancer (BC) patients with T1-2N1M0 who developed pathologically negative lymph…”
Get full text
Journal Article -
5
Is MPP a good prognostic factor in stage III lung adenocarcinoma with EGFR exon 19 mutation?
Published in Oncotarget (20-06-2017)“…Epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein encoded by a gene located in the short arm of chromosome 7. This study aimed to…”
Get full text
Journal Article -
6
Chemoradiotherapy-Induced CD4 + and CD8 + T-Cell Alterations to Predict Patient Outcomes in Esophageal Squamous Cell Carcinoma
Published in Frontiers in oncology (15-02-2019)“…Chemoradiotherapy (CRT) is an important component of treatment for patients with locally advanced esophageal squamous cell carcinoma (ESCC). Recent research…”
Get full text
Journal Article -
7
Brain metastasis in non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations: a report of seven cases and literature review
Published in Cancer biology & medicine (01-11-2017)“…Brain metastasis (BM) arising from non-small cell lung cancer (NSCLC) with rare epidermal growth factor receptor (EGFR) mutations is quite rare. The prognosis…”
Get full text
Journal Article -
8
High expression of Rad51c predicts poor prognostic outcome and induces cell resistance to cisplatin and radiation in non-small cell lung cancer
Published in Tumor biology (01-10-2016)“…Rad51c is critical for homologous recombination repair and genomic stability and may play roles in tumorigenesis and cancer therapy. We investigated the…”
Get full text
Journal Article -
9
NS1‐binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c‐Myc
Published in Cancer communications (London, England) (05-06-2018)“…Background Cisplatin‐based chemotherapy with concurrent radiotherapy is a standard treatment for advanced esophageal squamous cell carcinoma (ESCC)…”
Get full text
Journal Article -
10
Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma
Published in The oncologist (Dayton, Ohio) (01-07-2021)“…Lessons Learned Radiotherapy plus anti–PD‐1 antibody as first‐line therapy is safe and feasible in locally advanced esophageal squamous cell carcinoma (ESCC)…”
Get full text
Journal Article -
11
Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma who achieved clinical complete response when induction chemoradiation finished: A phase II random
Published in Radiotherapy and oncology (01-09-2022)“…BACKGROUND AND PURPOSEMore than 40% of patients with esophageal squamous cell carcinoma (ESCC) exhibit pathological complete responses (pCR) after neoadjuvant…”
Get full text
Journal Article -
12
A nomogram for predicting brain metastases of EGFR-mutated lung adenocarcinoma patients and estimating the efficacy of therapeutic strategies
Published in Journal of thoracic disease (01-02-2021)“…To establish a nomogram for predicting the outcome of EGFR-mutated lung adenocarcinoma patients with brain metastases (BMs) and to estimate the efficacy of…”
Get full text
Journal Article -
13
High expression of FUNDC1 predicts poor prognostic outcomes and is a promising target to improve chemoradiotherapy effects in patients with cervical cancer
Published in Cancer medicine (Malden, MA) (01-08-2017)“…FUN14 domain containing 1 (FUNDC1) is an important molecule in receptor‐dependent mitophagy. However, the roles of FUNDC1 in human cancer biology remain…”
Get full text
Journal Article -
14
The expression of PDGF-BB predicts curative effect in locally advanced esophageal squamous cell carcinoma treated by radiotherapy
Published in Aging (Albany, NY.) (24-04-2020)“…Radiotherapy is the major approach and is well tolerated in locally advanced esophageal squamous cell carcinoma (ESCC). And nowadays, no effective biological…”
Get full text
Journal Article -
15
Brain metastasis in non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations: a report of seven cases and literature review
Published in 癌症生物学与医学:英文版 (2017)“…Brain metastasis (BM) arising from non-small cell lung cancer (NSCLC) with rare epidermal growth factor receptor (EGFR) mutations is quite rare. The prognosis…”
Get full text
Journal Article -
16
Concurrent or Sequential Chemoradiotherapy after 3-4 Cycles Induction Chemotherapy for LS-SCLC with Bulky Tumor
Published in Journal of Cancer (01-01-2020)“…The current study was to compare the efficacy and safety between concurrent and sequential chemoradiotherapy after 3-4 cycles of induction chemotherapy for…”
Get full text
Journal Article -
17
Predictive value of EGF and uPAR for chemoradiotherapy response and survival in patients with esophageal squamous cell carcinoma
Published in Annals of translational medicine (01-09-2020)“…Chemoradiotherapy (CRT) plays a central role in the treatment of esophageal squamous cell carcinoma (ESCC). However, no effective biomarkers have been…”
Get full text
Journal Article -
18
The efficacy and safety of simultaneous integrated dose reduction in clinical target volume with intensity-modulated radiotherapy for patients with locally advanced esophageal squamous cell carcinoma
Published in Annals of translational medicine (01-09-2020)“…Compelling research to explore the effectiveness of simultaneous integrated dose reduction in clinical target volume (CTV) with intensity-modulated…”
Get full text
Journal Article -
19
Annual report of the esophageal cancer radiation group of the Department of Radiotherapy, Tianjin Medical University Cancer Institute & Hospital
Published in Annals of translational medicine (01-09-2020)“…This report describes the clinical work in esophageal cancer radiation group at the Department of Radiotherapy, Tianjin Medical University Cancer Institute &…”
Get full text
Journal Article -
20
PinX1 suppresses tumorigenesis by negatively regulating telomerase/telomeres in colorectal carcinoma cells and is a promising molecular marker for patient prognosis
Published in OncoTargets and therapy (01-01-2016)“…PinX1 plays positive and negative roles in the maintenance of telomerase and telomeres, as well as in tumorigenesis. The aim of the present study was to…”
Get full text
Journal Article